Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Healthy

Interventions

DRUG

BIA 3-202

Nebicapone tablets 200 mg

DRUG

warfarin

Varfine® 5 mg (warfarin 5 mg) tablets

Trial Locations (1)

Human Pharmacology Unit (UFH),, S. Mamede Do Coronado

All Listed Sponsors

lead

Bial - Portela C S.A.

INDUSTRY

NCT02779348 - Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin | Biotech Hunter | Biotech Hunter